Vishnu Chemicals posts 25% revenue growth in Q1FY27 on value shift
Vishnu Chemicals delivered robust Q1FY27 results with revenue up 25% and PAT up 23%, fueled by a strategic shift to high-margin derivatives and operational efficiency in barium. Despite margin pressure from freight costs and a one-time adjustment, the company is investing ₹200–250 crore in FY27 for DMSO, chrome oxide expansion, and solar energy to drive long-term value.

*this image is generated using AI for illustrative purposes only.
Vishnu Chemicals Limited reported a 24.9% year-on-year increase in operating revenue to ₹433.4 crore for the first quarter of fiscal year 2027 (Q1FY27), driven by a strategic shift toward higher-value derivatives and improved realizations in its barium segment. Profit after tax (PAT) rose 23% to ₹39.6 crore, reflecting the underlying resilience of the business despite headwinds from rising ocean freight costs due to geopolitical tensions in West Asia.
The company’s EBITDA grew 17.5% to ₹65.5 crore, though margins contracted slightly to 15.1% from 16.1% in Q1FY26, impacted by a one-time retrospective adjustment of ₹8 crore in baryte prices for the barium segment and higher logistics expenses. Management highlighted that the logistics cost as a percentage of revenue stood at 9–10% in Q1 but could rise to over 20% in the subsequent quarter due to ongoing supply chain disruptions.
Financial Highlights
| Metric | Q1FY27 | Q1FY26 | YoY Change |
|---|---|---|---|
| Operating Revenue | ₹433.4 crore | ₹346.9 crore | +24.9% |
| Gross Profit | ₹193.9 crore | ₹158.2 crore | +22.6% |
| EBITDA | ₹65.5 crore | ₹55.7 crore | +17.5% |
| EBITDA Margin | 15.1% | 16.1% | -100 bps |
| PAT | ₹39.6 crore | ₹32.2 crore | +23.0% |
| PAT Margin | 9.1% | 9.3% | -20 bps |
Strategic Shifts and Segment Performance
Siddartha Cherukuri, Joint Managing Director, emphasized a deliberate move away from base specialty chemicals toward higher-value derivatives in the chromium business. High-value derivatives now contribute nearly 50% of chromium sales, up from 40% in FY26, improving blended realizations. The barium segment continues to perform consistently with optimum capacity utilization, while the strontium business generated ₹25 crore in revenue, operating at 50% capacity against a total installed capacity of 10,000 tonnes.
The company is also advancing its backward integration strategy. Operations at its South African mine are expected to commence in the second half of FY27, following refurbishment and stabilization activities. This vertical integration aims to secure raw material supply and enhance gross margins, which currently stand at 44–45%, with a target of reaching 50% by year-end.
Capital Allocation and Future Outlook
Vishnu Chemicals plans a capital expenditure outlay of ₹200–250 crore for FY27. Key investments include:
- DMSO Project: ₹205–240 crore for Dimethyl Sulfoxide production, targeting import substitution in pharma and agro sectors.
- Chromium Derivatives: ₹50 crore to expand Chrome Oxide Green capacity, supported by a new long-term supply agreement with a European client.
- Barium Backward Integration: ₹40 crore to complete expansion projects.
- South Africa Mine: ₹20–25 crore for limited capital improvements.
- Solar Energy: ₹5–6 crore to expand solar power capacity from 5 MW to 20 MW, expected to reduce average power costs by 15–20%.
What the Numbers Show
The divergence between revenue growth (24.9%) and EBITDA growth (17.5%) highlights the pressure from rising input and logistics costs, partially offset by favorable product mix shifts. The one-time ₹8 crore charge in the barium segment masks underlying operational strength, as management maintains that sustainable EBITDA margins for barium remain around 25%. The significant investment in DMSO and Chrome Oxide Green signals a pivot toward higher-margin, specialty chemicals, aiming to reduce dependency on commodity-driven cycles and improve long-term profitability visibility.
Historical Stock Returns for Vishnu Chemicals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.26% | +4.14% | +2.44% | +27.05% | +29.38% | +448.75% |
How will the projected surge in logistics costs to over 20% of revenue in Q2FY27 impact Vishnu Chemicals' ability to maintain its target EBITDA margins, and what hedging strategies are in place?
Given the significant capital expenditure of ₹205–240 crore for the DMSO project, what is the expected timeline for achieving operational breakeven and contributing to bottom-line profitability?
With high-value derivatives now comprising 50% of chromium sales, how sustainable is this product mix shift against potential fluctuations in global pharma and agro demand?


































